Juno Therapeutics' (NASDAQ: JUNO) treatment chronic lymphocytic leukemia was granted FDA orphan drug status. Generic Name:autologous CD4+/CD8+ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE